momelotinib,fedratinib
gsk,bms
['mpnsm', '#mpn', 'momelotinib', 'fedra']
#eha2023 | poster | francesca palandri shares the safety outcomes of momelotinib vs fedratinib in jak-experienced and -na ve mf. momelotinib resulted in a more favorable safety profile, including a lower risk of any grade anemia in both cohorts. #mpn #mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm